TrialCNS drugs2026

Comparative Bioavailability of Trimodal (CTx-1301) Versus Bimodal Dexmethylphenidate Modified-Release Formulations in Adults with Attention-Deficit/Hyperactivity Disorder: A Randomized, Single-Dose, Crossover Study.

Arthur B Straughn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.